Lisette van Dam

Cost-effectiveness of MRI for diagnosing recurrent ipsilateral DVT 3 53 14. Linkins LA, Stretton R, Probyn L, Kearon C. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res . 2006;117(3):241-247. 15. Huisman MV, Klok FA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism. J Thromb Haemost . 2013;11(3):412-422. 16. Wells PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet . 1995;345(8961):1326-1330. 17. van Dam LF, Gautam G, Dronkers CEA, et al. Safety of using the combination of the Wells rule and D-dimer test for excluding acute recurrent ipsilateral deep vein thrombosis. J Thromb Haemost . 2020. 18. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost . 2005;3(4):692-694. 19. Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med . 2013;369(9):799-808. 20. Zorginstituut Nederland. Medicijnkosten. [Available from: https://www.medicijnkosten . nl/]. (January, 22, 2021) 21. Federatie van Nederlandse Trombosediensten. Samenvatting Medische jaarverslagen. [Available from: https://www.fnt.nl/algemeen/jaarverslagen ]. (January, 22, 2021) 22. van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet . 2017;390(10091):289-297. 23. Mansour S, Alotaibi G, Wu C, McMurtry MS. Trends in admission rates and in-hospital stay for venous thromboembolism. Thromb Res . 2017;156:149-154. 24. Dentali F, Di Micco G, Giorgi Pierfranceschi M, et al. Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice. Ann Med . 2015;47(7):546-554. 25. van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost . 2014;12(3):320-328. 26. Huisman MV, Büller HR, ten Cate JW, et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest . 1989;95(3):498- 502. 27. Bikdeli B, Wang Y, Jimenez D, et al. Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015. Jama . 2019;322(6):574-576. 28. Huisman MV, Barco S, Cannegieter SC, et al. Pulmonary embolism. Nat Rev Dis Primers . 2018;4:18028.